5 min read
Why My Favorite GLP-1 Titration Schedule Is No Schedule at All
Rushing up the GLP-1 dosing ladder is a great way to make yourself miserable. Here is why staying at the lowest effective dose for as long as possible is the smartest move.
BLOG / CATEGORY
Semaglutide, tirzepatide and retatrutide: dose ranges, side effect patterns, and how the three actually compare.
Rushing up the GLP-1 dosing ladder is a great way to make yourself miserable. Here is why staying at the lowest effective dose for as long as possible is the smartest move.
An experienced look at why rushing your GLP-1 titration is a recipe for side effects, wasted research funds, and hitting an early plateau.
Daily weight fluctuations are a mental trap, especially when using research peptides. Here is how to actually track your progress without losing your sanity.
We freak out over a temporary red flush but completely ignore the slow creep of fatigue, joint pressure, and sketchy vial purity. Here is what you actually need to watch out for.
The secret to researching GLP-1 peptides isn't finding the highest dose, it's staying at the lowest effective dose for as long as possible. Here is why patience wins.
Forget the clinical trial pamphlets. Here is what actually happens when you compare semaglutide and tirzepatide in the real world, from food apathy to the hit on your wallet.
Retatrutide is the new shiny thing, tirzepatide is the safe bet, and almost nobody talks about the boring parts. Here is what I actually think.